Fig. 1
From: Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter
Expression of EGR1 in GBMLGG. a The mRNA levels of EGR1 in giloma tissues and normal brain tissues. P = 0.024. b The mRNA levels of EGR1 in giloma tissues and normal brain tissues, data come from TCGA databases. c Immunoblot analysis of EGR1 total protein levels in glioma tissues and normal brain tissues. d Relative protein levels of EGR1 were determined by Western blotting. The levels of EGR1 were normalized to those of β-ACTIN. P = 0.0447. e. Kaplan-Meier analysis of the GBMLGG RNA-seq data were from the The Cancer Genome Atlas (TCGA) databases. *P < 0.05, (mean ± SEM, Student’s t-test)